Related Experiment Video
Updated: Aug 11, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
The potential role of m6A modifications on immune cells and immunotherapy
Linchuan Gan1, Yuxiang Zhao1, Yajuan Fu1
1Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University Qishan Campus, College Town, Fuzhou, Fujian Province 350117, PR China.
Abstract:
N6-methyladenosine (m6A), is the most prevalent and reversible post-transcriptional epigenetic modification of RNA in mammals. Dysregulation of m6A modifications impacts RNA procession, degradation, translocation, and translation, disrupting immune cell homeostasis and promoting tumor initiation and development. Here, we discuss an -up-to-date summary of the mechanisms by which m6A modifications regulate immune cell anti-tumor as well as self-homeostasis. We also present how the dysregulation of m6A modifications intrinsic to tumor cells regulates the function of immune cells in the tumor microenvironment. Meanwhile, we described some specific inhibitors targeting m6A modulators and discussed their potential use in cancer treatments.
Insights
N6-methyladenosine (m6A) RNA modifications are crucial for immune cell balance and cancer development. Understanding m6A
Area of Science:
- Molecular Biology
- Epigenetics
- Immunology
Background:
- N6-methyladenosine (m6A) is the most common RNA modification in mammals.
- m6A dysregulation affects RNA processing, immune homeostasis, and tumor progression.
Purpose of the Study:
- To summarize m6A's role in immune cell anti-tumor and self-homeostasis.
- To explore how tumor-intrinsic m6A affects the tumor microenvironment.
- To discuss m6A inhibitors for cancer therapy.
Main Methods:
- Literature review and synthesis of current research on m6A modifications.
- Analysis of m6A's impact on immune cell function and tumor development.
- Review of targeted m6A inhibitor strategies.
Main Results:
- m6A modifications are critical regulators of immune cell homeostasis and anti-tumor immunity.
- Tumor cell m6A dysregulation influences immune cell activity within the tumor microenvironment.
- Specific m6A inhibitors show promise for cancer treatment.
Conclusions:
- m6A plays a significant role in both immune regulation and cancer progression.
- Targeting m6A pathways offers a potential therapeutic strategy for cancer.
- Further research into m6A modulators is warranted for clinical application.
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Microorganisms in Medicine and Therapeutics
Mesenchymal Stem Cells

